4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Boiron SA (BOI) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Messimy, France with about 2,364 employees. Its market capitalization is roughly €458 million. In the fiscal year ended 2025-12-31, BOI reported €501M in revenue and €33M in net income.
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | €501M | €488M | €493M | €534M |
| Gross Profit | €366M | €359M | €358M | €380M |
| Operating Income (EBIT) | €36M | €36M | €41M | €57M |
| Net Income | €33M | €11M | €36M | €45M |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (€21M) | (€23M) | (€199M) | (€16M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €603M | €576M | €590M | €790M | — |
| Total Liabilities | €210M | €198M | €199M | €232M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BOI viewer.
About TickerBase · Data methodology & sources · Privacy · Terms